Invention is an essential feature of business. The best inventions are created when you mix talented people playing to their strengths in an environment of open collaboration, working in partnership with clients and suppliers with a clear focus on commercial goals.
Exciting and varied work that makes a difference. A collaborative culture where you can take on complex technical challenges and deliver commercial impact. That's life at TTP.
The sights of Artificial Intelligence (AI) can be trained on almost any business problem that will benefit from automation. But what if training data for your problem is in short supply? In this blog, Simon Shakespeare shares a few tricks for training AI without reinventing the algorithmic wheel or by creating training data out of thin air.
2018 was a busy one for the US Food and Drug Administration. Drug approvals hit a record high, with 59 novel drugs securing the agency’s permission to head to market. This included a number of drugs with modes of action that transcend the two main classes of drugs.
Microneedle systems pose multidisciplinary R&D challenges—some because of and some despite the much smaller size of the needles involved. But microneedle systems also offer exciting new prospects for drug delivery and multiplex biomarker detection. This information could be used to guide personalised treatment or enable value-based healthcare.
PCR is still the go-to method in the molecular diagnostics industry but, with the rise of close-to-patient testing, isothermal amplification methods with their low power and potentially easier detection schemes look increasingly attractive.
TTP is returning to Satellite 2019 in Washington DC on 6 – 9 May, booth 110.
TTP is proud to be supporting Race for Science on 30 March 2019.
Read our application note: Vortex-Actuated Cell Sorting for New Research and Clinical Applications as it appeared in GEN
TTP plc completes expansion of life sciences lab facility for Desktop Biology programmes
